An overview of prognostic factors for long-term survivors of breast cancer. Soerjomataram, I., Louwman, M. W. J., Ribot, J. G., Roukema, J. A., & Coebergh, J. W. W. Breast Cancer Research and Treatment, 107(3):309--330, February, 2008. ![An overview of prognostic factors for long-term survivors of breast cancer [link]](https://bibbase.org/img/filetypes/link.svg "link")
Paper doi abstract bibtex Background Numerous studies have examined prognostic factors for survival of breast cancer patients, but relatively few have dealt specifically with 10+-year survivors. Methods A review of the PubMed database from 1995 to 2006 was undertaken with the following inclusion criteria: median/mean follow-up time at least 10 years; overall survival and/or disease-specific survival known; and relative risk and statistical probability values reported. In addition, we used data from the long-standing Eindhoven Cancer Registry to illustrate survival probability as indicated by various prognostic factors. Results 10-year breast cancer survivors showed 90% 5-year relative survival. Tumor size, nodal status and grade remained the most important prognostic factors for long-term survival, although their role decreased over time. Most studies agreed on the long-term prognostic values of MI (mitotic index), LVI (lymphovascular invasion), Her2-positivity, gene profiling and comorbidity for either all or a subgroup of breast cancer patients (node-positive or negative). The roles of age, socioeconomic status, histological type, BRCA and p53 mutation were mixed, often decreasing after correction for stronger prognosticators, thus limiting their clinical value. Local and regional recurrence, metastases and second cancer may substantially impair long-term survival. Healthy lifestyle was consistently related to lower overall mortality. Conclusions Effects of traditional prognostic factors persist in the long term and more recent factors need further follow-up. The prognosis for breast cancer patients who have survived at least 10 years is favourable and increases over time. Improved long-term survival can be achieved by earlier detection, more effective modern therapy and healthier lifestyle.
@article{soerjomataram_overview_2008,
title = {An overview of prognostic factors for long-term survivors of breast cancer},
volume = {107},
issn = {0167-6806},
url = {http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2217620/},
doi = {10.1007/s10549-007-9556-1},
abstract = {Background
Numerous studies have examined prognostic factors for survival of breast cancer patients, but relatively few have dealt specifically with 10+-year survivors.
Methods
A review of the PubMed database from 1995 to 2006 was undertaken with the following inclusion criteria: median/mean follow-up time at least 10 years; overall survival and/or disease-specific survival known; and relative risk and statistical probability values reported. In addition, we used data from the long-standing Eindhoven Cancer Registry to illustrate survival probability as indicated by various prognostic factors.
Results
10-year breast cancer survivors showed 90\% 5-year relative survival. Tumor size, nodal status and grade remained the most important prognostic factors for long-term survival, although their role decreased over time. Most studies agreed on the long-term prognostic values of MI (mitotic index), LVI (lymphovascular invasion), Her2-positivity, gene profiling and comorbidity for either all or a subgroup of breast cancer patients (node-positive or negative). The roles of age, socioeconomic status, histological type, BRCA and p53 mutation were mixed, often decreasing after correction for stronger prognosticators, thus limiting their clinical value. Local and regional recurrence, metastases and second cancer may substantially impair long-term survival. Healthy lifestyle was consistently related to lower overall mortality.
Conclusions
Effects of traditional prognostic factors persist in the long term and more recent factors need further follow-up. The prognosis for breast cancer patients who have survived at least 10 years is favourable and increases over time. Improved long-term survival can be achieved by earlier detection, more effective modern therapy and healthier lifestyle.},
number = {3},
urldate = {2013-04-19},
journal = {Breast Cancer Research and Treatment},
author = {Soerjomataram, Isabelle and Louwman, Marieke W. J. and Ribot, Jacques G. and Roukema, Jan A. and Coebergh, Jan Willem W.},
month = feb,
year = {2008},
pmid = {17377838},
pmcid = {PMC2217620},
pages = {309--330},
file = {PubMed Central Full Text PDF:files/38435/Soerjomataram et al. - 2008 - An overview of prognostic factors for long-term su.pdf:application/pdf}
}
Downloads: 0
{"_id":"XyymGSMknyvkPRmXe","bibbaseid":"soerjomataram-louwman-ribot-roukema-coebergh-anoverviewofprognosticfactorsforlongtermsurvivorsofbreastcancer-2008","downloads":0,"creationDate":"2016-09-09T06:27:31.818Z","title":"An overview of prognostic factors for long-term survivors of breast cancer","author_short":["Soerjomataram, I.","Louwman, M. W. J.","Ribot, J. G.","Roukema, J. A.","Coebergh, J. W. W."],"year":2008,"bibtype":"article","biburl":"https://www.sfu.ca/~howlett/howlett16.bib","bibdata":{"bibtype":"article","type":"article","title":"An overview of prognostic factors for long-term survivors of breast cancer","volume":"107","issn":"0167-6806","url":"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2217620/","doi":"10.1007/s10549-007-9556-1","abstract":"Background Numerous studies have examined prognostic factors for survival of breast cancer patients, but relatively few have dealt specifically with 10+-year survivors. Methods A review of the PubMed database from 1995 to 2006 was undertaken with the following inclusion criteria: median/mean follow-up time at least 10 years; overall survival and/or disease-specific survival known; and relative risk and statistical probability values reported. In addition, we used data from the long-standing Eindhoven Cancer Registry to illustrate survival probability as indicated by various prognostic factors. Results 10-year breast cancer survivors showed 90% 5-year relative survival. Tumor size, nodal status and grade remained the most important prognostic factors for long-term survival, although their role decreased over time. Most studies agreed on the long-term prognostic values of MI (mitotic index), LVI (lymphovascular invasion), Her2-positivity, gene profiling and comorbidity for either all or a subgroup of breast cancer patients (node-positive or negative). The roles of age, socioeconomic status, histological type, BRCA and p53 mutation were mixed, often decreasing after correction for stronger prognosticators, thus limiting their clinical value. Local and regional recurrence, metastases and second cancer may substantially impair long-term survival. Healthy lifestyle was consistently related to lower overall mortality. Conclusions Effects of traditional prognostic factors persist in the long term and more recent factors need further follow-up. The prognosis for breast cancer patients who have survived at least 10 years is favourable and increases over time. Improved long-term survival can be achieved by earlier detection, more effective modern therapy and healthier lifestyle.","number":"3","urldate":"2013-04-19","journal":"Breast Cancer Research and Treatment","author":[{"propositions":[],"lastnames":["Soerjomataram"],"firstnames":["Isabelle"],"suffixes":[]},{"propositions":[],"lastnames":["Louwman"],"firstnames":["Marieke","W.","J."],"suffixes":[]},{"propositions":[],"lastnames":["Ribot"],"firstnames":["Jacques","G."],"suffixes":[]},{"propositions":[],"lastnames":["Roukema"],"firstnames":["Jan","A."],"suffixes":[]},{"propositions":[],"lastnames":["Coebergh"],"firstnames":["Jan","Willem","W."],"suffixes":[]}],"month":"February","year":"2008","pmid":"17377838","pmcid":"PMC2217620","pages":"309--330","file":"PubMed Central Full Text PDF:files/38435/Soerjomataram et al. - 2008 - An overview of prognostic factors for long-term su.pdf:application/pdf","bibtex":"@article{soerjomataram_overview_2008,\n\ttitle = {An overview of prognostic factors for long-term survivors of breast cancer},\n\tvolume = {107},\n\tissn = {0167-6806},\n\turl = {http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2217620/},\n\tdoi = {10.1007/s10549-007-9556-1},\n\tabstract = {Background\nNumerous studies have examined prognostic factors for survival of breast cancer patients, but relatively few have dealt specifically with 10+-year survivors.\n\nMethods\nA review of the PubMed database from 1995 to 2006 was undertaken with the following inclusion criteria: median/mean follow-up time at least 10 years; overall survival and/or disease-specific survival known; and relative risk and statistical probability values reported. In addition, we used data from the long-standing Eindhoven Cancer Registry to illustrate survival probability as indicated by various prognostic factors.\n\nResults\n10-year breast cancer survivors showed 90\\% 5-year relative survival. Tumor size, nodal status and grade remained the most important prognostic factors for long-term survival, although their role decreased over time. Most studies agreed on the long-term prognostic values of MI (mitotic index), LVI (lymphovascular invasion), Her2-positivity, gene profiling and comorbidity for either all or a subgroup of breast cancer patients (node-positive or negative). The roles of age, socioeconomic status, histological type, BRCA and p53 mutation were mixed, often decreasing after correction for stronger prognosticators, thus limiting their clinical value. Local and regional recurrence, metastases and second cancer may substantially impair long-term survival. Healthy lifestyle was consistently related to lower overall mortality.\n\nConclusions\nEffects of traditional prognostic factors persist in the long term and more recent factors need further follow-up. The prognosis for breast cancer patients who have survived at least 10 years is favourable and increases over time. Improved long-term survival can be achieved by earlier detection, more effective modern therapy and healthier lifestyle.},\n\tnumber = {3},\n\turldate = {2013-04-19},\n\tjournal = {Breast Cancer Research and Treatment},\n\tauthor = {Soerjomataram, Isabelle and Louwman, Marieke W. J. and Ribot, Jacques G. and Roukema, Jan A. and Coebergh, Jan Willem W.},\n\tmonth = feb,\n\tyear = {2008},\n\tpmid = {17377838},\n\tpmcid = {PMC2217620},\n\tpages = {309--330},\n\tfile = {PubMed Central Full Text PDF:files/38435/Soerjomataram et al. - 2008 - An overview of prognostic factors for long-term su.pdf:application/pdf}\n}\n\n","author_short":["Soerjomataram, I.","Louwman, M. W. J.","Ribot, J. G.","Roukema, J. A.","Coebergh, J. W. W."],"key":"soerjomataram_overview_2008","id":"soerjomataram_overview_2008","bibbaseid":"soerjomataram-louwman-ribot-roukema-coebergh-anoverviewofprognosticfactorsforlongtermsurvivorsofbreastcancer-2008","role":"author","urls":{"Paper":"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2217620/"},"downloads":0},"search_terms":["overview","prognostic","factors","long","term","survivors","breast","cancer","soerjomataram","louwman","ribot","roukema","coebergh"],"keywords":[],"authorIDs":[],"dataSources":["Bn7xRaKMY43f7hFwh"]}